Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. MYO
stocks logo

MYO

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
9.15M
+21.62%
--
--
13.33M
+44.72%
--
--
17.95M
+48.74%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -50.55%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-50.55%
In Past 3 Month
5 Analyst Rating
up Image0
Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 9.05 USD with a low forecast of 6.75 USD and a high forecast of 11.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
up Image0
Current: 2.710
sliders
Low
6.75
Averages
9.05
High
11.00
up Image0
Current: 2.710
sliders
Low
6.75
Averages
9.05
High
11.00
Craig-Hallum
Buy
downgrade
$11 -> $10
2025-05-08
Reason
Craig-Hallum
Price Target
$11 -> $10
2025-05-08
downgrade
Buy
Reason
Craig-Hallum lowered the firm's price target on Myomo to $10 from $11 and keeps a Buy rating on the shares following a mixed Q1 update. Q2 guidance disappointed, with revenue expected between $9.0M-$9.5M versus Street expectations of $10.9M.
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$9 → $11
2025-03-17
Reason
Ascendiant Capital
Edward Woo
Price Target
$9 → $11
2025-03-17
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Sean Lee
Strong Buy
Maintains
$7.5 → $9.5
2025-03-12
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5 → $9.5
2025-03-12
Maintains
Strong Buy
Reason
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$9 → $11
2025-03-11
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$9 → $11
2025-03-11
Maintains
Strong Buy
Reason
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$7 → $9
2024-12-13
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$7 → $9
2024-12-13
Maintains
Strong Buy
Reason
Myomo announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Myomo expects to use the net proceeds of the offering, together with its existing cash and cash equivalents, to accelerate its revenue growth by funding an increase in advertising expenses and headcount to support the expected revenue growth in Myomo's direct billing channel, along with investments in systems to support growth in the O&P channel and in scaling its operations. In addition, the net proceeds of the offering will be used to fund product development and sustaining engineering activities to enhance the current MyoPro product line and to develop the next generation of Myomo's products, with the remainder for working capital and general corporate purposes. Craig-Hallum Capital Group is acting as the sole managing underwriter for the offering.
HC Wainwright & Co.
Sean Lee
Strong Buy
Reiterates
$7.5
2024-11-13
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5
2024-11-13
Reiterates
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Myomo Inc (MYO.A) is -21.21, compared to its 5-year average forward P/E of -11.52. For a more detailed relative valuation and DCF analysis to assess Myomo Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-11.52
Current PE
-21.21
Overvalued PE
2.22
Undervalued PE
-25.26

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-12.19
Current EV/EBITDA
-25.60
Overvalued EV/EBITDA
10.18
Undervalued EV/EBITDA
-34.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.63
Current PS
2.02
Overvalued PS
4.23
Undervalued PS
1.04

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
Bought

MYO News & Events

Events Timeline

(ET)
2025-05-07
17:12:40
Myomo reports Q1 EPS (8c), consensus (8c)
select
2025-03-10 (ET)
2025-03-10
16:12:32
Myomo reports Q4 EPS (1c), consensus (2c)
select
2024-12-04 (ET)
2024-12-04
15:07:32
Myomo announces common stock offering, no amount given
select
Sign Up For More Events
Sign Up For More Events

News

Preview
1.0
06-18Newsfilter
Myomo Provides Highlights of Today's Investor & Analyst Day Event
  • Investor & Analyst Day Overview: Myomo, Inc. is hosting an Investor & Analyst Day to review its business model, showcase its new headquarters and manufacturing facility, and discuss long-term financial goals, including aspirations for $100 million in annual revenue by 2028.

  • Future Projections and Challenges: Management will present strategies for lead generation, Medicare reimbursement improvements, and plans to enhance manufacturing capacity while addressing potential risks that could impact the company's financial performance and growth trajectory.

Preview
4.0
06-05Benzinga
Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $11.5
  • Real-time Trading Intelligence: Benzinga Pro offers the fastest and most accurate stock market news alerts to help traders succeed in their investments.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and insights generated by Benzinga reporters.

Preview
1.0
05-01Newsfilter
Myomo to Host Investor & Analyst Day Event on June 18, 2025
  • Investor & Analyst Day Announcement: Myomo, Inc. will host its first Investor & Analyst Day on June 18, 2025, at its new headquarters in Burlington, Massachusetts, featuring presentations on innovations, strategic plans, and product demonstrations related to their wearable medical robotics for individuals with neuromuscular disorders.

  • Event Details: The event will include a guided tour of the facility, Q&A sessions with executives, and networking opportunities, with both in-person attendance and a live webcast available for participants.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Myomo Inc (MYO) stock price today?

The current price of MYO is 2.71 USD — it has decreased -1.45 % in the last trading day.

arrow icon

What is Myomo Inc (MYO)'s business?

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

arrow icon

What is the price predicton of MYO Stock?

Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 9.05 USD with a low forecast of 6.75 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Myomo Inc (MYO)'s revenue for the last quarter?

Myomo Inc revenue for the last quarter amounts to 9.83M USD, increased 161.88 % YoY.

arrow icon

What is Myomo Inc (MYO)'s earnings per share (EPS) for the last quarter?

Myomo Inc. EPS for the last quarter amounts to -0.08 USD, decreased -20.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Myomo Inc (MYO)'s fundamentals?

The market is revising No Change the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -50.55%.
arrow icon

How many employees does Myomo Inc (MYO). have?

Myomo Inc (MYO) has 184 emplpoyees as of June 20 2025.

arrow icon

What is Myomo Inc (MYO) market cap?

Today MYO has the market capitalization of 97.50M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free